A new study shows that Chromax, the brand of chromium picolinate marketed by US firm Nutrition 21, is better absorbed by the body than other forms of this compound used as nutritional supplements and in foods. The results of the study, conducted by Ohio State University Department of Nutrition, USA, were presented at the Federation of American Societies for Experimental Biology annual meeting held earlier this month.
The trial compared the absorption of four different types of nutritional chromium at a dose of 200mcg, in the form of: Chromax chromium picolinate, chromium chloride, chromium niacin amino acid chelate and chromium nicotinate. The researchers found that women who consumed chromium supplements absorbed a significantly higher amount of chromium picolinate, as compared with the other three types, based on 24-hour urine content analysis.
Absorption of chromium from chromium chloride was found to be very low and not much different than baseline. Chromium chloride is commonly used in multivitamin and mineral formulations for consumption as supplements and is also widely utilized in vitamin and mineral pre-mixes for food fortification.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze